Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 9302

1.

Mutation analysis of BRCA1/2 mutations with special reference to polymorphic SNPs in Indian breast cancer patients.

Shah ND, Shah PS, Panchal YY, Katudia KH, Khatri NB, Ray HSP, Bhatiya UR, Shah SC, Shah BS, Rao MV.

Appl Clin Genet. 2018 May 9;11:59-67. doi: 10.2147/TACG.S155955. eCollection 2018.

PMID:
29785135
2.

Tyrosine kinase inhibitor-induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors.

Maifrede S, Nieborowska-Skorska M, Sullivan K, Dasgupta Y, Podszywalow-Bartnicka P, Le BV, Solecka M, Lian Z, Belyaeva EA, Nersesyan A, Machnicki MM, Toma M, Chatain N, Rydzanicz M, Zhao H, Jelinek J, Piwocka K, Sliwinski T, Stoklosa T, Ploski R, Fischer T, Sykes SM, Koschmieder S, Bullinger L, Valent P, Wasik M, Huang J, Skorski T.

Blood. 2018 May 21. pii: blood-2018-02-834895. doi: 10.1182/blood-2018-02-834895. [Epub ahead of print]

PMID:
29784639
3.

The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma.

Park HJ, Bae JS, Kim KM, Moon YJ, Park SH, Ha SH, Hussein UK, Zhang Z, Park HS, Park BH, Moon WS, Kim JR, Jang KY.

J Exp Clin Cancer Res. 2018 May 21;37(1):107. doi: 10.1186/s13046-018-0772-9.

PMID:
29784019
4.

Leucocytes telomere length and breast cancer risk/ susceptibility: A case-control study.

Pavanello S, Varesco L, Gismondi V, Bruzzi P, Bolognesi C.

PLoS One. 2018 May 21;13(5):e0197522. doi: 10.1371/journal.pone.0197522. eCollection 2018.

5.

BRCA1 Mutations Associated With Increased Risk of Brain Metastases in Breast Cancer: A 1: 2 Matched-pair Analysis.

Zavitsanos PJ, Wazer DE, Hepel JT, Wang Y, Singh K, Leonard KL.

Am J Clin Oncol. 2018 May 18. doi: 10.1097/COC.0000000000000466. [Epub ahead of print]

PMID:
29782359
6.

Emerging strategies in BRCA-positive pancreatic cancer.

Kowalewski A, Szylberg Ł, Saganek M, Napiontek W, Antosik P, Grzanka D.

J Cancer Res Clin Oncol. 2018 May 18. doi: 10.1007/s00432-018-2666-9. [Epub ahead of print] Review.

PMID:
29777302
7.

Age at first full-term birth and breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Kotsopoulos J, Gronwald J, Lynch HT, Eisen A, Neuhausen SL, Tung N, Ainsworth P, Weitzel JN, Pal T, Foulkes WD, Eng C, Singer CF, Senter L, Sun P, Lubinski J, Narod SA; Hereditary Breast Cancer Clinical Study Group.

Breast Cancer Res Treat. 2018 May 17. doi: 10.1007/s10549-018-4822-y. [Epub ahead of print]

PMID:
29774471
8.

Frequency of Rearrangements Versus Small Indels Mutations in <i>BRCA1</i> and <i>BRCA2</i> Genes in Turkish Patients with High Risk Breast and Ovarian Cancer.

Yazıcı H, Kılıç S, Akdeniz D, Şükrüoğlu Ö, Tuncer ŞB, Avşar M, Kuru G, Çelik B, Küçücük S, Saip P.

Eur J Breast Health. 2018 Apr 1;14(2):93-99. doi: 10.5152/ejbh.2017.3799. eCollection 2018 Apr.

9.

Investigation of Experimental Factors That Underlie BRCA1/2 mRNA Isoform Expression Variation: Recommendations for Utilizing Targeted RNA Sequencing to Evaluate Potential Spliceogenic Variants.

Lattimore VL, Pearson JF, Currie MJ, Spurdle AB; kConFab Investigators, Robinson BA, Walker LC.

Front Oncol. 2018 May 3;8:140. doi: 10.3389/fonc.2018.00140. eCollection 2018.

10.

Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube.

Choi MC, Bae JS, Jung SG, Park H, Joo WD, Song SH, Lee C, Kim JH, Lee KC, Lee S, Lee JH.

J Gynecol Oncol. 2018 Mar 26. doi: 10.3802/jgo.2018.29.e43. [Epub ahead of print]

11.

Association of BRCA2 K3326* With Small Cell Lung Cancer and Squamous Cell Cancer of the Skin.

Rafnar T, Sigurjonsdottir GR, Stacey SN, Halldorsson G, Sulem P, Pardo LM, Helgason H, Sigurdsson ST, Gudjonsson T, Tryggvadottir L, Olafsdottir GH, Jonasson JG, Alexiusdottir K, Sigurdsson A, Gudmundsson J, Saemundsdottir J, Sigurdsson JK, Johannsdottir H, Uitterlinden A, Vermeulen SH, Galesloot TE, Allain DC, Lacko M, Sigurgeirsson B, Thorisdottir K, Johannsson OT, Sigurdsson F, Ragnarsson GB, Isaksson H, Hardardottir H, Gudbjartsson T, Gudbjartsson DF, Masson G, Kiemeney LAML, Ewart Toland A, Nijsten T, Peters WHM, Olafsson JH, Jonsson S, Thorsteinsdottir U, Thorleifsson G, Stefansson K.

J Natl Cancer Inst. 2018 May 14. doi: 10.1093/jnci/djy002. [Epub ahead of print]

PMID:
29767749
12.

Mixing Mutation Location With Carcinogen Exposure: A Recipe for Tissue Specificity in BRCA2-Associated Cancers?

Pathania S, Garber JE.

J Natl Cancer Inst. 2018 May 14. doi: 10.1093/jnci/djy047. [Epub ahead of print] No abstract available.

PMID:
29767746
13.

Genetic dissection of the BRCA2 promoter and transcriptional impact of DNA variants.

Fraile-Bethencourt E, Valenzuela-Palomo A, Díez-Gómez B, Infante M, Durán M, Marcos G, Lastra E, Gómez-Barrero S, Velasco EA.

Breast Cancer Res Treat. 2018 May 15. doi: 10.1007/s10549-018-4826-7. [Epub ahead of print]

PMID:
29766361
14.

BRCA2 Mutation as a Possible Cause of Poor Response to 177Lu-PSMA Therapy.

Ahmadzadehfar H, Gaertner F, Lossin PS, Schwarz B, Essler M.

Clin Nucl Med. 2018 May 14. doi: 10.1097/RLU.0000000000002141. [Epub ahead of print]

PMID:
29762244
15.

Editorial: BRCA1 and BRCA2 gene mutations screening in sporadic breast cancer patients in Kazakhstan.

Jankowitz RC, Knickelbein KZ.

Cent Asian J Glob Health. 2013 May 21;2(1):41. doi: 10.5195/cajgh.2013.41. eCollection 2013. No abstract available.

PMID:
29755873
16.

<i>BRCA1</i> and <i>BRCA2</i> Gene Mutations Screening In Sporadic Breast Cancer Patients In Kazakhstan.

Akilzhanova AR, Nyshanbekkyzy B, Nurkina ZM, Shtephanov II, Makishev AK, Adylkhanov TA, Rakhypbekov TK, Ramanculov EM, Momynaliev KT.

Cent Asian J Glob Health. 2013 May 21;2(1):29. doi: 10.5195/cajgh.2013.29. eCollection 2013.

PMID:
29755871
17.

Genomic landscape and prognostic analysis of mantle cell lymphoma.

Yang P, Zhang W, Wang J, Liu Y, An R, Jing H.

Cancer Gene Ther. 2018 May 14. doi: 10.1038/s41417-018-0022-5. [Epub ahead of print]

PMID:
29755111
18.

The role of PARP inhibition in triple-negative breast cancer: Unraveling the wide spectrum of synthetic lethality.

Papadimitriou M, Mountzios G, Papadimitriou CA.

Cancer Treat Rev. 2018 May 2;67:34-44. doi: 10.1016/j.ctrv.2018.04.010. [Epub ahead of print] Review.

PMID:
29753961
19.

Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.

Waszak SM, Northcott PA, Buchhalter I, Robinson GW, Sutter C, Groebner S, Grund KB, Brugières L, Jones DTW, Pajtler KW, Morrissy AS, Kool M, Sturm D, Chavez L, Ernst A, Brabetz S, Hain M, Zichner T, Segura-Wang M, Weischenfeldt J, Rausch T, Mardin BR, Zhou X, Baciu C, Lawerenz C, Chan JA, Varlet P, Guerrini-Rousseau L, Fults DW, Grajkowska W, Hauser P, Jabado N, Ra YS, Zitterbart K, Shringarpure SS, De La Vega FM, Bustamante CD, Ng HK, Perry A, MacDonald TJ, Hernáiz Driever P, Bendel AE, Bowers DC, McCowage G, Chintagumpala MM, Cohn R, Hassall T, Fleischhack G, Eggen T, Wesenberg F, Feychting M, Lannering B, Schüz J, Johansen C, Andersen TV, Röösli M, Kuehni CE, Grotzer M, Kjaerheim K, Monoranu CM, Archer TC, Duke E, Pomeroy SL, Shelagh R, Frank S, Sumerauer D, Scheurlen W, Ryzhova MV, Milde T, Kratz CP, Samuel D, Zhang J, Solomon DA, Marra M, Eils R, Bartram CR, von Hoff K, Rutkowski S, Ramaswamy V, Gilbertson RJ, Korshunov A, Taylor MD, Lichter P, Malkin D, Gajjar A, Korbel JO, Pfister SM.

Lancet Oncol. 2018 May 9. pii: S1470-2045(18)30242-0. doi: 10.1016/S1470-2045(18)30242-0. [Epub ahead of print]

20.

Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer.

Li J, Jing R, Wei H, Wang M, Qi X, Liu H, Liu J, Ou J, Jiang W, Tian F, Sheng Y, Li H, Xu H, Zhang R, Guan A, Liu K, Jiang H, Ren Y, He J, Huang W, Liao N, Cai X, Ming J, Ling R, Xu Y, Hu C, Zhang J, Guo B, Ouyang L, Shuai P, Liu Z, Zhong L, Zeng Z, Zhang T, Xuan Z, Tan X, Liang J, Pan Q, Chen L, Zhang F, Fan L, Zhang Y, Yang X, Li J, Chen C, Jiang J.

Int J Cancer. 2018 May 12. doi: 10.1002/ijc.31601. [Epub ahead of print]

PMID:
29752822

Supplemental Content

Loading ...
Support Center